• PDF: Delivered by email usually within 12 to 24 UK business hours.

Incyte Corporation - Pharmaceuticals & Healthcare
Deals and Alliances Profile

Incyte Corporation - Pharmaceuticals & Healthcare Deals and Alliances Profile

Incyte Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Incyte Corporation (Incyte) is engaged in discovery and development of small molecule drugs to treat serious unmet medical needs in the field of oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its products include INCB18424, INCB28050, INCB13739, INCB7839 for Inflammation, Hematologic Malignancies, and Solid Tumors; INCB28060, INCB24360 for treatment of cancer; INCB19602 for type 2 diabetes; INCB9471 and INCB15050 for treatment of HIV. The company is headquartered in Wilmington in Delaware, United States.

Global Market Direct's Incyte Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

  • Provides key company information for business intelligence needs
  • Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

  • A quick ""one-stop-shop"" to understand the company.
  • Support sales activities by understanding your customers' businesses.
  • Qualify prospective partners and suppliers.
  • Understand and respond to your competitors' business structure, strategy and prospects through.
  • Understanding the key deals which have shaped the company.
Table Of Contents Table Of Contents 2 List of Tables 3 List of Figures 3 Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Incyte Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5 Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7 Incyte Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8 Incyte Corporation, Pharmaceuticals & Healthcare, Deal Details 9 Incyte Completes Private Placement Of $10 Million 9 Incyte Completes Private Placement Of $151.8 Million 10 Incyte Completes Private Placement Of Convertible Notes $10 Million 11 Incyte Completes Private Placement Of $250 Million 12 Divestiture - Company 13 Agilent Technologies Acquires Velocity11 13 Equity Offering 14 Incyte Completes Public Offering Of $108.67 Million 14 Genomic Health Completes Private Placement Of $5 Million 15 Incyte Completes Public Offering Of $87.75 Million 16 Partnerships 17 Incyte Enters Into An Agreement With Pfizer 17 Incyte Enteres Into An Agreement With Roche Diagnostics 18 Venture Financing 19 diaDexus Secures $20 Million In Series D Funding 19 Key Competitors 21 Key Employees 21 Locations And Subsidiaries 22 Head Office 22 Other Locations & Subsidiaries 22 Appendix 23 Methodology 23 About Global Markets Direct 23 Contact Us 23 Disclaimer 23 List of Tables Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Incyte Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5 Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Incyte Corporation, Deals By Sector, 2004 to YTD 2009 7 Incyte Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8 Incyte Completes Private Placement Of $10 Million 9 Incyte Completes Private Placement Of $151.8 Million 10 Incyte Completes Private Placement Of Convertible Notes $10 Million 11 Incyte Completes Private Placement Of $250 Million 12 Agilent Technologies Acquires Velocity11 13 Incyte Completes Public Offering Of $108.67 Million 14 Genomic Health Completes Private Placement Of $5 Million 15 Incyte Completes Public Offering Of $87.75 Million 16 Incyte Enters Into An Agreement With Pfizer 17 Incyte Enteres Into An Agreement With Roche Diagnostics 18 diaDexus Secures $20 Million In Series D Funding 19 Incyte Corporation, Key Employees 21 Incyte Corporation, Subsidiaries 22 List of Figures Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Incyte Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5 Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Incyte Corporation, Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
+44 20 8816 8548

Ask a question about Incyte Corporation - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha